We’re Here for You: Temporary Email Disruption We want to make sure none of your important requests slip through the cracks. Due to an ongoing Microsoft service outage, our team may not have received emails sent to us since 12:00 PM (Noon) EST on Thursday. Your business is our priority, and we don’t want this delay to hold you back. If you sent an email after noon Thursday, or if you have a time-sensitive matter that needs attention right away, please give your BDC representative a call directly. We are standing by and ready to help you over the phone.

We’re Here for You: Temporary Email Disruption We want to make sure none of your important requests slip through the cracks. Due to an ongoing Microsoft service outage, our team may not have received emails sent to us since 12:00 PM (Noon) EST on Thursday. Your business is our priority, and we don’t want this delay to hold you back. If you sent an email after noon Thursday, or if you have a time-sensitive matter that needs attention right away, please give your BDC representative a call directly. We are standing by and ready to help you over the phone.
FR
Search
Search
Milestone Pharmaceuticals logo
Portfolio company

Milestone Pharmaceuticals

Details
Region
Quebec
Industry sector
Drugs
Investment year
2012
Fund
Healthcare Venture Fund, Go Capital Fund
Learn more
Our partnership

Milestone Pharma is a BDC Capital Healthcare Venture Fund company, co-managed in partnership by Amplitude Venture Capital.

Contact

Dion Madsen, Founding partner at Amplitude Venture Capital.

About the company

Milestone is a drug development company developing novel small molecule therapeutics based on clinically validated mechanisms for cardiovascular diseases. Milestone’s lead product is a novel and potent short-acting calcium channel antagonist for the systemic treatment of transient cardiovascular conditions such as atrial arrhythmias and angina.